Asia-Pacific infectious disease diagnostics market trends

In Asia-Pacific (APAC), many countries continue to build up in vitro diagnostics (IVD) testing capacity to strengthen the country’s response to infectious diseases. Clearstate expects infectious disease testing to grow.

The infectious disease immunoassays market is expected to grow between 1.5% to 12.3% annually between 2023 to 2026 in APAC markets tracked by Clearstate’s Infectious Diseases Trend Monitor. Infectious disease testing using next-generation sequencing technology is expected to grow by more than 10% in markets such as China and India. The infectious disease point-of-care testing (POCT) market is expected to shrink in the same period in most markets as covid-19 test volumes drop drastically.

  • Respiratory diseases are expected to be a key focus area for many countries. Currently, there is a high testing and diagnosis rates for respiratory diseases in countries such as Japan due to established influenza and RTI surveillance systems.
  • Underdiagnosis of infectious diseases is occurring in some market segments, evident in disparities in the diagnosis rate of Tier 1 cities and rural areas in diseases such as HIV and hepatitis.
  • IVD companies are facing growing competition from Asian IVD manufacturers, such as South Korea’s Seegene and China’s Wondfo and Da An. Asian brands entering markets such as the point-of-care (POC) segment are likely to place price pressure in the coming years. 
  • Molecular diagnostics (MDx) technology to support infectious disease testing has become more accessible since the pandemic. 
  • In some markets, there is growing potential for infectious disease test volume to shift from core laboratory diagnostics to MDx as the cost of the latter falls post-pandemic.

Monitor IVD trends driving the infectious disease diagnostics market in APAC

As challenges posed by infectious diseases continue to evolve in APAC, Clearstate’s comprehensive data and analysis on infectious disease testing can help businesses strengthen their response to shifting disease trends and meet future demand for testing.

Infectious diseases trend monitor

Understand local infectious disease dynamics and how it impacts testing. Our comprehensive data and analysis on emerging and endemic infections from covid-19 to hepatitis helps your business strengthen response to shifting disease trends and meet future demand for testing.